Wolfe Research Maintains Outperform on Merck & Co, Raises Price Target to $180

Benzinga Newsdesk www.benzinga.com Positive 90.3%

Neg 0% Neu 0% Pos 90.3%

Wolfe Research analyst Alexandria Hammond maintains Merck & Co (NYSE:MRK) with a Outperform and raises the price target from $155 to $180.